BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

662 related articles for article (PubMed ID: 20077378)

  • 1. [Effects of a mandatory guideline that prohibit hospital doctors from accepting any form of benefits in any form from the pharmaceutical industry].
    Gundermann C; Meier-Hellmann A; Bauer M; Hartmann M
    Dtsch Med Wochenschr; 2010 May; 135(3):67-70. PubMed ID: 20077378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Is it pertinent to investigate the relations between physicians and the drug industry].
    Moliner J; Mozota J; Abad JM; Casaña L; Júdez D; Rabanaque MJ
    Rev Calid Asist; 2009 Apr; 24(2):72-9. PubMed ID: 19426930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "But doctors do it...": nurses' views of gifts and information from the pharmaceutical industry.
    Jutel A; Menkes DB
    Ann Pharmacother; 2009 Jun; 43(6):1057-63. PubMed ID: 19470854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A population-based study of the prevalence and influence of gifts to radiation oncologists from pharmaceutical companies and medical equipment manufacturers.
    Halperin EC; Hutchison P; Barrier RC
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1477-83. PubMed ID: 15275735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient awareness and concern regarding pharmaceutical manufacturer interactions with doctors.
    Edwards D; Ballantyne A
    Intern Med J; 2009 Mar; 39(3):191-6. PubMed ID: 19383067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unconscious conflict of interest: a Jewish perspective.
    Gold A; Appelbaum PS
    J Med Ethics; 2011 Jul; 37(7):402-5. PubMed ID: 20852304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The attitude of physicians regarding the promotion strategies of the pharmaceutical industry].
    Castresana L; Mejia R; Aznar M
    Medicina (B Aires); 2005; 65(3):247-51. PubMed ID: 16042137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Physicians and drug industry: attitudes and practice].
    Aasland OG; Førde R
    Tidsskr Nor Laegeforen; 2004 Oct; 124(20):2603-6. PubMed ID: 15534631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Teaching appropriate interactions with pharmaceutical company representatives: the impact of an innovative workshop on student attitudes.
    Wofford JL; Ohl CA
    BMC Med Educ; 2005 Feb; 5(1):5. PubMed ID: 15698480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Why academic medical centers should ban drug company gifts to individuals.
    Strong C
    Am J Bioeth; 2010 Jan; 10(1):13-5. PubMed ID: 20077327
    [No Abstract]   [Full Text] [Related]  

  • 11. The medical profession and the pharmaceutical industry: when will we open our eyes?
    Breen KJ
    Med J Aust; 2004 Apr; 180(8):409-10. PubMed ID: 15089732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lets Do Lunch? The ethics of accepting gifts from the pharmaceutical industry.
    Hagen B; Pijl-Zieber EM; Souveny K; Lacroix A
    Can Nurse; 2008 Apr; 104(4):30-5. PubMed ID: 18488765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medicine and the pharmaceutical industry: a call to action.
    Stiles MM; Barrett B
    Am Fam Physician; 2007 May; 75(10):1447, 1451; discussion 1451. PubMed ID: 17555137
    [No Abstract]   [Full Text] [Related]  

  • 14. Industry relations with emergency medicine graduate medical education programs.
    Kowalenko T; Char D; Marco C; Asher S; Raja A; Farrell S; Sokolove PE;
    Acad Emerg Med; 2009 Oct; 16(10):1025-30. PubMed ID: 19799581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Why self-regulation does not work: resolving prescription corruption caused by excessive gift-giving by pharmaceutical manufacturers.
    Mehta RS
    Food Drug Law J; 2008; 63(4):799-821. PubMed ID: 19593922
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmaceutical industry influences on physician prescribing: gifts, quasi-gifts, and patient-directed gifts.
    Berger JT
    Am J Bioeth; 2003; 3(3):56-7. PubMed ID: 14594495
    [No Abstract]   [Full Text] [Related]  

  • 17. Banning pens and pads misses the main point.
    Terry SF; Burke W
    Am J Bioeth; 2003; 3(3):63-5. PubMed ID: 14594500
    [No Abstract]   [Full Text] [Related]  

  • 18. Residents' perceptions over time of pharmaceutical industry interactions and gifts and the effect of an educational intervention.
    Schneider JA; Arora V; Kasza K; Van Harrison R; Humphrey H
    Acad Med; 2006 Jul; 81(7):595-602. PubMed ID: 16799279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to open peer commentaries on "The pitfalls of deducing ethics from economics: why the Association of American Medical Colleges is wrong about pharmaceutical detailing".
    Huddle TS
    Am J Bioeth; 2010 Jan; 10(1):W1-3. PubMed ID: 20077322
    [No Abstract]   [Full Text] [Related]  

  • 20. Contact with pharmaceutical representatives: where does prudence lead?
    Appelbaum PS
    Am J Bioeth; 2010 Jan; 10(1):11-3. PubMed ID: 20077326
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 34.